Heidelberg Biolabs GmbH jobs and careers

About Heidelberg Biolabs GmbH

The research products and services offered by Heidelberg Biolabs are based on thoroughly optimized protocols and various know-how developed at the German Cancer Research Center and University Hospital Heidelberg over the last decade. Our methodology secures the analysis of ultra-low RNA inputs with unprecedented efficacy, sensitivity, and robustness. Our translational research initiative is being realized in the form of an innovative "Mi-Test" for preventive diagnostics of multiple pathological conditions based on extracellular RNA signatures in human blood and other biological fluids. The current version of Heidelberg Biolabs "Mi-Test" implies qPCR-based measurement of several miRNAs expressed exclusively in the myocardial cells, and which presence in the blood plasma can be a smart indicator of the ongoing cell death in the myocardium. Such surveillance of the health status by measuring organ-specific miRNAs (along with other circulating RNA species) in biofluids can be performed at point-of-care stations complementing the conventional blood tests in the future.